| Foreword |
|
vii | |
| Preface |
|
xi | |
|
Neurobiology of Attention and Executive Control |
|
|
1 | (16) |
|
Attention and Executive Control |
|
|
2 | (3) |
|
Neuropsychological Models of Attention |
|
|
5 | (8) |
|
Neurochemical Basis of Attention |
|
|
11 | (1) |
|
|
|
12 | (1) |
|
Neuropsychological Models of Executive Control |
|
|
13 | (1) |
|
|
|
14 | (1) |
|
|
|
15 | (2) |
|
Continuous Performance Test Paradigms and What They Do |
|
|
17 | (38) |
|
The Original CPT Paradigm |
|
|
18 | (1) |
|
Modifications of the Original Paradigm |
|
|
19 | (23) |
|
Effects of Differences in CPT Parameters |
|
|
42 | (3) |
|
Other Factors Known to Influence CPT Performance |
|
|
45 | (3) |
|
Scores Reported for the CPT |
|
|
48 | (6) |
|
|
|
54 | (1) |
|
Major CPTs in Clinical Use: Configuration, Use, and Technical Adequacy |
|
|
55 | (52) |
|
Task Demands and Descriptive Information |
|
|
64 | (7) |
|
The Conners' Continuous Performance Test |
|
|
64 | (1) |
|
|
|
65 | (2) |
|
Integrated (or Intermediate) Visual and Auditory Continuous Performance Test |
|
|
67 | (2) |
|
Test of Variables of Attention |
|
|
69 | (2) |
|
Adequacy of Normative Data |
|
|
71 | (8) |
|
|
|
72 | (2) |
|
|
|
74 | (2) |
|
|
|
76 | (1) |
|
|
|
77 | (1) |
|
|
|
78 | (1) |
|
CPT Score Formats and Tables |
|
|
79 | (10) |
|
|
|
86 | (1) |
|
|
|
87 | (1) |
|
|
|
88 | (1) |
|
|
|
88 | (1) |
|
|
|
89 | (3) |
|
|
|
90 | (1) |
|
|
|
90 | (1) |
|
|
|
90 | (1) |
|
|
|
91 | (1) |
|
Reliability and Validity Studies |
|
|
92 | (10) |
|
|
|
98 | (1) |
|
|
|
99 | (1) |
|
|
|
100 | (1) |
|
|
|
101 | (1) |
|
Discussion and Conclusion |
|
|
102 | (5) |
|
The Relationship of CPTs to Other Cognitive and Behavioral Measures |
|
|
107 | (52) |
|
|
|
109 | (46) |
|
Relations with Other Measures |
|
|
119 | (1) |
|
|
|
119 | (8) |
|
|
|
127 | (4) |
|
|
|
131 | (3) |
|
|
|
134 | (12) |
|
Personality and Symptom Presentation in Adults |
|
|
146 | (6) |
|
|
|
152 | (3) |
|
|
|
155 | (4) |
|
Brain-Behavior Correlates of CPT Scores |
|
|
159 | (31) |
|
Support for CPT Performance as Reflecting CNS Dysfunction |
|
|
160 | (28) |
|
Effects of Diffuse Damage |
|
|
162 | (7) |
|
Anterior-Posterior Gradient |
|
|
169 | (11) |
|
Differential Response to Target Stimuli |
|
|
180 | (2) |
|
|
|
182 | (2) |
|
Neural Substrates of CPT Performance and Psychopathology |
|
|
184 | (1) |
|
Effects of Task Variations on Neurophysiological Correlates |
|
|
185 | (2) |
|
Association with Demographic Variables |
|
|
187 | (1) |
|
|
|
188 | (2) |
|
Diagnostic Efficacy of CPTs for Disorders Usually First Evident in Childhood or Adolescence |
|
|
190 | (43) |
|
Sensitivity and Specificity |
|
|
191 | (1) |
|
Differential Group Performance |
|
|
192 | (37) |
|
|
|
193 | (2) |
|
|
|
195 | (2) |
|
ADHD-Conduct Disorder Comparisons |
|
|
197 | (1) |
|
ADHD and Other Group Comparisons |
|
|
198 | (1) |
|
|
|
198 | (1) |
|
Schizophrenia, High Risk for Schizophrenia, and CPTs |
|
|
199 | (1) |
|
|
|
199 | (1) |
|
|
|
200 | (1) |
|
|
|
201 | (1) |
|
CPTs and Tourette's Syndrome |
|
|
202 | (1) |
|
|
|
203 | (26) |
|
|
|
229 | (4) |
|
Diagnostic Efficacy of CPTs for Disorders in Adulthood |
|
|
233 | (25) |
|
|
|
234 | (1) |
|
CPTs and Adult Schizophrenia |
|
|
235 | (3) |
|
Age and Medication Effects |
|
|
236 | (1) |
|
|
|
237 | (1) |
|
Active Schizophrenia and Cases in Remission |
|
|
237 | (1) |
|
Comparison with Other Groups |
|
|
238 | (1) |
|
|
|
238 | (1) |
|
CPTs and Bipolar Disorder |
|
|
238 | (1) |
|
|
|
239 | (1) |
|
|
|
240 | (1) |
|
CPTs and Environmental Neurotoxic Exposure |
|
|
241 | (1) |
|
|
|
242 | (1) |
|
|
|
243 | (13) |
|
|
|
256 | (2) |
|
Monitoring Medication Effects with Continuous Performance Tests |
|
|
258 | (33) |
|
|
|
260 | (13) |
|
|
|
273 | (2) |
|
|
|
273 | (1) |
|
|
|
274 | (1) |
|
|
|
275 | (1) |
|
|
|
275 | (1) |
|
|
|
275 | (5) |
|
Antianxiety (Anxiolytic) and Antihypertensive Medications |
|
|
280 | (2) |
|
|
|
280 | (1) |
|
|
|
281 | (1) |
|
Anticonvulsants/Antiepileptics |
|
|
282 | (2) |
|
|
|
284 | (2) |
|
|
|
284 | (1) |
|
|
|
285 | (1) |
|
|
|
285 | (1) |
|
Antihistamines and Asthma Medications |
|
|
285 | (1) |
|
Studies with Leisure Drugs, Caffeine, Nicotine, or High Sugars |
|
|
286 | (2) |
|
|
|
286 | (2) |
|
|
|
288 | (1) |
|
|
|
288 | (3) |
|
CPTs in Monitoring Effectiveness of Other Treatment Approaches |
|
|
291 | (15) |
|
Status of Empirical Support for Treatment Programs |
|
|
293 | (10) |
|
CPTs as a Pre-/Postindex of Effectiveness |
|
|
294 | (5) |
|
|
|
299 | (4) |
|
|
|
303 | (3) |
|
Where Do We Go from Here? |
|
|
306 | (9) |
|
Will the Real CPT Please Stand Up? |
|
|
307 | (1) |
|
Standardization of Administration |
|
|
308 | (1) |
|
|
|
309 | (2) |
|
Sensitivity and Specificity |
|
|
311 | (1) |
|
|
|
311 | (2) |
|
|
|
313 | (2) |
| References |
|
315 | (60) |
| About the Authors |
|
375 | (3) |
| Author Index |
|
378 | (9) |
| Subject Index |
|
387 | |